Tolmetin

DEA Class;  Rx

Common Brand Names; Tolectin

 NSAIDs

Nonsteroidal anti-inflammatory drug (NSAID) of the heterocyclic acetic acid chemical class
Used for osteoarthritis and rheumatoid arthritis in adults; also used in pediatric patients as young as 2 years for juvenille idiopathic arthritis (JIA)
All NSAIDs may cause an increased risk of serious gastrointestinal or cardiovascular events; use lowest effective dose for the shortest possible duration

For the treatment of acute flares or for the chronic management of rheumatoid arthritis or osteoarthritis.

For the treatment of juvenile rheumatoid arthritis (JRA)/juvenile idiopathic arthritis (JIA).

Absolute: ASA allergy, hepatic disease (severe chronic), hepatitis, jaundice, nursing mother

Relative: Bleeding disorder, duodenal/gastric/peptic ulcer, stomatitis, SLE, ulcerative colitis, upper GI disease, late pregnancy (may cause premature closure of ductus arteriosus)

>10%

Increased liver function test (up to 15%)

1-10%

Nausea (10%)

Hypertension (3-9%)

Myocardial infarction (<2%)

Edema

Weight gain, Weight loss

Abdominal pain

Diarrhea

Flatulence

Indigestion

Nausea, Vomiting

Asthenia

Dizziness

Headache

Use caution in asthma (bronchial), cardiac disease, CHF, hepatic impairment, HTN, renal impairment

Long-term administration of NSAIDs may result in renal papillary necrosis and other renal injury; patients at greatest risk include the elderly, or those with impaired renal function, hypovolemia, heart failure, liver dysfunction, salt depletion, and individuals taking diuretics, ACE inhibitors, or ARBs

Strong cross-sensitivity may exist for ASA allergic patients

Food reduces bioavailability

Heart Failure(HF) risk

Pregnancy Category: C; avoid in late pregnancy, may cause premature closure of ductus arteriosus

Lactation: excreted in breast milk; safety in nursing infants not known

Adults

1,800 mg/day PO.

Geriatric

1,800 mg/day PO.

Adolescents

30 mg/kg/day PO or 1,800 mg/day PO, whichever is less.

Children

2 to 12 years: 30 mg/kg/day PO or 1,800 mg/day PO, whichever is less.
Less than 2 years: Safety and efficacy have not been established.

Infants

Safety and efficacy have not been established.

Neonates

Safety and efficacy have not been established.

tablet

  • 200mg
  • 600mg

capsule

  • 400mg

About the Author

You may also like these

0